Litigation and Trial Brief - Trial Strategy Today

CAFC Reverses Massive Jury Verdict for Juno and Sloan Kettering

IP Watchdog

AUGUST 26, 2021

The jury ultimately found in Juno’s favor and, in post-trial briefs, Kite moved for judgment as a matter of law (JMOL) on several grounds, including that the claims were not supported by sufficient written description. Juno sued Kite Pharma, Inc. for infringement of the ‘190 patent through the sale of its YESCARTA product.

Trial Brief

Trial Brief Evidence Technology Pharmaceuticals

Another Director Review Request Demonstrates Extent of PTAB Hubris

IP Watchdog

MAY 14, 2025

-based patent owner (Efficient Power Conversion), but the challenge was instituted after completion of a week-long trial at the International Trade Commission (ITC) and during the process of post-trial briefing.

Trial Brief

Trial Brief Technology Litigation

Trial Strategy Today

CAFC Reverses Massive Jury Verdict for Juno and Sloan Kettering

Another Director Review Request Demonstrates Extent of PTAB Hubris

Webinars

Stay Connected